Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Erbitux

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Erbitux was produced by Merck & Co. and Bristol-Myers Squibb.

Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer

Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer

Drug approved in combination with Merck's KGaA's Erbitux. French pharma group Pierre Fabre’s Braftovi has been recommended for NHS use by the UK’s National Institute for Health ... Braftovi (encorafenib) combined with has been recommended Merck

MSD’s Keytruda scores another EU okay, in head and neck cancer

MSD’s Keytruda scores another EU okay, in head and neck cancer cancer for a decade – the EXTREME regimen of Eli Lilly’s Erbitux (cetuximab) with a platinum drug plus 5-FU – in the PD-L1-expressing group.

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial It also sells gastrointestinal cancer antibodies Erbitux (cetuximab) and recently launched Cyramza (ramucirumab), but was a late entrant into the cancer immunotherapy sector, and the Armo deal is viewed as a

Innate Pharma and AstraZeneca take monalizumab into phase 3

Innate Pharma and AstraZeneca take monalizumab into phase 3 The biotech – based in Marseille, France – will proceed into a phase 3 trial evaluating monalizumab in combination with Eli Lilly’s Erbitux (cetuximab) in patients suffering from recurrent or metastatic squamous

Lilly buys Armo for $1.6bn to bolster immuno-oncology pipeline

Lilly buys Armo for $1.6bn to bolster immuno-oncology pipeline It also sells gastrointestinal cancer antibodies Erbitux (cetuximab) and recently launched Cyramza (ramucirumab).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...